Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy. Study results showed that patients new to antidepressant treatment and those who had restarted therapy after a lapse of 6 or more months were twice as likely to discontinue therapy in the first 30 days of treatment versus patients previously dispensed an antidepressant.
Popularity: unranked [?]
Related posts:
- STAR*D Depression Study Finds Cognitive Therapy Equivalent To Medication But Selected By Fewer Patients
- Suicide Risk Does Not Increase When Adults Start Using Antidepressants, Study Finds
- Suicide Risk Does Not Increase When Adults Start Using Antidepressants, Study Finds
- Study Finds Primary Care Depression Treatment Often Does Not Follow Quality Guidelines
- NeuroStar(R) TMS Therapy Improved Quality Of Life In Patients With Major Depression In Clinical Trials

Comments
No Responses to “Adheris Study Finds Antidepressant Discontinuation Most Likely At The Start Of Therapy Among Newly Treated And Previously Lapsed Patients”